on DBV TECHNOLOGIES (EPA:DBV)
DBV Technologies Releases Annual Financial Reports
DBV Technologies, a biopharmaceutical company specializing in food allergy treatments, announced the publication of its 2024 Form 10-K and Universal Registration Document (URD). The audited financial statements for fiscal year 2024, approved by the Board of Directors on April 11, 2025, have not been changed from the previously published unaudited versions.
The documents were filed with the SEC in the United States and the AMF in France, respectively. The DEU contains the Annual Financial Report, the Management Report, and the description of the Share Repurchase Program. They are available on the DBV Technologies website as well as on the AMF and SEC websites.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all DBV TECHNOLOGIES news